Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Google patents us patent application vinblastine vindoline claim biosynthesis?Avacopan analyst forecast?What's the impact of lipitor on ssri treated patients?When does the patent for janumet expire?Is azithromycin still on patent today?
See the DrugPatentWatch profile for Skyla
How long does Skyla stay effective after insertion? Skyla is a levonorgestrel intrauterine system that releases hormone for up to 36 months (three years) from the date of insertion. After that period the device no longer meets the FDA‑approved safety and efficacy standards and is considered expired for contraceptive use. What happens when Skyla reaches its 3‑year limit? Once the 3‑year window closes, the IUS may still be physically present in the uterus, but its hormone output falls below the therapeutic threshold. Using it beyond this time can reduce contraceptive reliability and increase the risk of unintended pregnancy. It also may lead to changes in local tissue response. When should I schedule a replacement? Most clinicians advise scheduling a follow‑up visit at the 24‑month mark to assess placement and discuss future plans. If you plan to continue using Skyla, a replacement should be inserted before the 36‑month mark. If you are no longer interested in using Skyla, you can have it removed at any time. Can I keep Skyla past its expiry, and what are the risks? Staying with Skyla after 36 months is not recommended. The device’s hormone release drops, and the risk of pregnancy increases. Some users may also experience changes in bleeding patterns or pelvic discomfort as the device ages. Is there a patent expiry that might affect pricing? The original Skyla patents, such as US 8,210,549 (levonorgestrel IUS system) and related formulation patents, expire in the early 2030s. When the key patents lapse, generic manufacturers can produce biosimilar or generic versions, potentially lowering costs. Current projections put the critical patent expirations around 2032–2035, which could open the market to competition. Does the device have a shelf life before insertion? Skyla’s packaging includes an expiration date that reflects the stability of the levonorgestrel coating and the device’s mechanical integrity. The FDA requires that the IUS be used before its listed shelf‑life date, which is typically two to three years from manufacture. --- Sources [1] https://www.fda.gov/medical-devices/medical-device-approvals/approval-process-levonorgestrel-intrauterine-system-skyla [2] https://www.drugpatentwatch.com/patent/8210549 [3] https://www.abbott.com/products/skyla-intrauterine-system.html
Other Questions About Skyla :